当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:159.77亿  总市值:159.77亿
流通股本:2.12亿   总股本:2.12亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.49亿元,每股收益0.72元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益304642.17万元,未分配利润94161.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产584254.59万元,负债279612.43万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,310,942,751.62606,125,018.692,270,177,811.51,619,063,344.9
营业总成本1,083,752,794.05500,107,881.661,900,882,004.661,383,328,088.18
其他经营收益
营业利润184,723,905.8274,892,596.81236,817,376.92157,760,861.72
利润总额181,622,375.2373,258,571.58238,355,281.35157,832,706.43
净利润148,696,287.3161,178,293.66197,930,034.58140,779,655.41
每股收益
其他综合收益-2,272,927.51200,385.5422,673,517.3914,035,099.29
综合收益总额146,423,359.861,378,679.2220,603,551.97154,814,754.7
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,509,468,693.463,363,203,135.353,174,918,772.72,376,880,587.7
非流动资产:
非流动资产合计2,333,077,224.832,350,325,759.872,330,027,122.572,306,622,057.7
资产总计5,842,545,918.295,713,528,895.225,504,945,895.274,683,502,645.4
流动负债:
流动负债合计1,446,644,840.331,363,851,756.861,260,187,291.81,210,004,419.4
非流动负债:
非流动负债合计1,349,479,419.531,376,317,512.221,340,503,672.54751,777,802.32
负债合计2,796,124,259.862,740,169,269.082,600,690,964.341,961,782,221.72
所有者权益(或股东权益):
归属于母公司股东权益合计3,023,109,057.762,948,187,946.512,877,877,144.942,704,179,683.13
股东权益合计3,046,421,658.432,973,359,626.142,904,254,930.932,721,720,423.68
负债和股东权益合计5,842,545,918.295,713,528,895.225,504,945,895.274,683,502,645.4
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,342,097,615.26581,435,370.722,360,017,508.131,654,346,586.74
经营活动现金流出小计1,352,528,504.77613,937,047.151,978,057,249.821,495,338,546.22
经营活动产生的现金流量净额-10,430,889.51-32,501,676.43381,960,258.31159,008,040.52
投资活动产生的现金流量:
投资活动现金流入小计2,006,738,023.231,074,094,217.3329,357,419.5219,913,172.04
投资活动现金流出小计1,736,278,461.611,011,057,176.63813,011,609.64199,118,409.29
投资活动产生的现金流量净额270,459,561.6263,037,040.7-783,654,190.12-179,205,237.25
筹资活动产生的现金流量:
筹资活动现金流入小计493,284,158.35291,805,529.861,633,575,712.21605,040,019.79
筹资活动现金流出小计306,405,488.22136,872,625.76842,097,185.26568,561,561.84
筹资活动产生的现金流量净额186,878,670.13154,932,904.1791,478,526.9536,478,457.95
汇率变动对现金及现金等价物的影响14,329,706.168,134,951.467,845,113.984,215,590.65
现金及现金等价物净增加额461,237,048.4193,603,219.83397,629,709.1220,496,851.87
期末现金及现金等价物余额1,334,332,721.131,066,698,892.56873,095,672.73495,962,815.48
补充资料:
现金及现金等价物的净增加额461,237,048.4-397,629,709.12-
最新报告期:2025-10-13
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通1.441.882.342025-10-13
中信建投王云鹏,袁清慧,贺菊颖1.401.922.482025-09-02
开源证券余汝意,聂媛媛1.391.912.452025-08-30
太平洋周豫,张崴1.451.882.442025-08-29
信达证券唐爱金1.411.812.242025-08-29
TOP↑